Asia-Pacific Pharmaceuticals and others establish new company including drug import and export business.

According to the Qi Cha Cha APP, Zhejiang Yataixinghao Pharmaceutical Co., Ltd. was recently established, with Feng Yunhua as the legal representative and a registered capital of 10 million yuan. Its business scope includes: pharmaceutical wholesale; pharmaceutical production; pharmaceutical retail; pharmaceutical import and export; pharmaceutical internet information services; and the production of class II medical devices. Corporate equity penetration information shows that the company is jointly held by Zhejiang Yataili Zhong Holdings Co., Ltd., a wholly-owned subsidiary of Asia-Pacific Pharmaceuticals, and Hainan Taizefeng Medical Technology Co., Ltd.